Cargando…

Rationale for therapeutic decision-making in locally advanced and metastatic radioactive iodine (RAI)-refractory differentiated thyroid cancer, starting from a clinical case

Iodine uptake and organification are the hallmarks of thyroid cells differentiation. The loss of these characteristics in thyroid cancer leads to radioactive iodine refractoriness, a rare condition that bears a low survival rate and poor prognosis. We present a 52-year-old patient presenting dry cou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silaghi, Cristina Alina, Stãnoiu-Pînzariu, Oana, Silaghi, Horaţiu, Piciu, Doina, Georgescu, Carmen Emanuela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	UMF “Gr. T. Popa” Iasi Publishing House 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717005/ https://www.ncbi.nlm.nih.gov/pubmed/34984230 http://dx.doi.org/10.22551/2021.33.0804.10190

Ejemplares similares

The Prognostic Value of MicroRNAs in Thyroid Cancers—A Systematic Review and Meta-Analysis
por: Silaghi, Cristina Alina, et al.
Publicado: (2020)

A virtual reality-based intervention for surgical patients: study protocol of a randomized controlled trial
por: Georgescu, Raluca Diana, et al.
Publicado: (2021)

State of the Art in the Current Management and Future Directions of Targeted Therapy for Differentiated Thyroid Cancer
por: Silaghi, Horatiu, et al.
Publicado: (2022)

Thyroseq v3, Afirma GSC, and microRNA Panels Versus Previous Molecular Tests in the Preoperative Diagnosis of Indeterminate Thyroid Nodules: A Systematic Review and Meta-Analysis
por: Silaghi, Cristina Alina, et al.
Publicado: (2021)

Thyroid storm following radioactive iodine (RAI) therapy for pediatric graves disease
por: Rohrs, Henry J., et al.
Publicado: (2014)

Xanthogranuloma of the Sellar Region: A Comprehensive Review of Neuroimaging in a Rare Inflammatory Entity
por: Lozovanu, Vera, et al.
Publicado: (2022)

Molecular Pathology and Targeted Therapies for Personalized Management of Central Nervous System Germinoma
por: Ilcus, Cristina, et al.
Publicado: (2021)

Prevalence and predictors of non-alcoholic fatty liver disease as defined by the fatty liver index in a type 2 diabetes population
por: SILAGHI, CRISTINA ALINA, et al.
Publicado: (2016)

Rationale and design of decision: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyroid cancer
por: Brose, Marcia S, et al.
Publicado: (2011)

Identification of Radioactive Iodine Refractory Differentiated Thyroid Cancer
por: Mu, Zhuan-Zhuan, et al.
Publicado: (2019)

Quantitative thyroglobulin response to radioactive iodine treatment in predicting radioactive iodine-refractory thyroid cancer with pulmonary metastasis
por: Wang, Chen, et al.
Publicado: (2017)

Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy
por: Liu, Jierui, et al.
Publicado: (2019)

Impact of Sarcopenia on the Severity of the Liver Damage in Patients With Non-alcoholic Fatty Liver Disease
por: Zambon Azevedo, Vittoria, et al.
Publicado: (2022)

Second malignancies in patients with differentiated thyroid carcinoma treated with low and medium activities of radioactive I-131
por: PICIU, DOINA, et al.
Publicado: (2016)

Effectiveness of Fixed Dose Radioactive Iodine (RAI) for the Treatment of Hyperthyroidism: Experience of a Teaching Hospital in South West Nigeria
por: Enyi Ejeh M, John, et al.
Publicado: (2013)

MON-590 Outcomes Following Radioactive Iodine Therapy (RAI) in Hyperthyroid Patients with Grave’s Disease and Toxic Nodular Disease
por: Aljenaee, Khaled, et al.
Publicado: (2019)

Sorafenib in radioactive iodine-refractory well-differentiated metastatic thyroid cancer
por: McFarland, Daniel C, et al.
Publicado: (2014)

The Genomic Landscape of Radioactive Iodine Refractory and Avid Papillary Thyroid Carcinomas
por: Al-Kuraya, Khawla Sami, et al.
Publicado: (2021)

Radioactive iodine-refractory differentiated thyroid cancer: an uncommon but challenging situation
por: Schmidt, Angelica, et al.
Publicado: (2017)

SAT520 Efficacy of Radioactive Iodine Redifferentiation Therapy in Previously Iodine Refractory Differentiated Thyroid Cancers
por: Toro-Tobon, David, et al.
Publicado: (2023)

Health state utility valuation in radioactive iodine-refractory differentiated thyroid cancer
por: Fordham, Beth A, et al.
Publicado: (2015)

Patient-Derived Papillary Thyroid Cancer Organoids for Radioactive Iodine Refractory Screening
por: Sondorp, Luc H.J., et al.
Publicado: (2020)

The efficacy and safety in radioactive iodine refractory thyroid cancer patients treated with sorafenib
por: Ling, Yuanna, et al.
Publicado: (2023)

Targeting GLI1 Transcription Factor for Restoring Iodine Avidity with Redifferentiation in Radioactive-Iodine Refractory Thyroid Cancers
por: Oh, Ji Min, et al.
Publicado: (2022)

PSAT345 Neonatal Graves (NG) Affecting 3 Newborns of a Mother Treated with Radioactive Iodine (RAI) for Graves’ Disease (GD)
por: Ali, Dalal S, et al.
Publicado: (2022)

Patient Benefit-Risk Tradeoffs for Radioactive Iodine-Refractory Differentiated Thyroid Cancer Treatments
por: Mohamed, Ateesha F., et al.
Publicado: (2015)

Editorial: Apatinib and Anlotinib in the Treatment of Radioactive Iodine Refractory and Highly Invasive Thyroid Carcinoma
por: Jia, Wenqing, et al.
Publicado: (2022)

Metabolomics—A Promising Approach to Pituitary Adenomas
por: Pînzariu, Oana, et al.
Publicado: (2019)

Challenges of thyroid cancer management in amiodarone-treated patients: a case report
por: PETRULEA, MIRELA SANDA, et al.
Publicado: (2015)

Thrombotic Microangiopathy with Severe Proteinuria Induced by Lenvatinib for Radioactive Iodine-Refractory Papillary Thyroid Carcinoma
por: Hyogo, Yasuko, et al.
Publicado: (2018)

AXL Is a Novel Predictive Factor and Therapeutic Target for Radioactive Iodine Refractory Thyroid Cancer
por: Collina, Francesca, et al.
Publicado: (2019)

Adolescents’ Lifestyle Determinants in Relation to Their Nutritional Status during COVID-19 Pandemic Distance Learning in the North-Western Part of Romania—A Cross-Sectional Study
por: Nasui, Bogdana Adriana, et al.
Publicado: (2023)

Impact of 18F-FDG PET/CT on Clinical Management of Suspected Radio-Iodine Refractory Differentiated Thyroid Cancer (RAI-R-DTC)
por: Lodi Rizzini, Elisa, et al.
Publicado: (2021)

On the Origin of the Blue Color in The Iodine/Iodide/Starch Supramolecular Complex
por: Pesek, Szilárd, et al.
Publicado: (2022)

Targeted Treatment Options of Recurrent Radioactive Iodine Refractory Hürthle Cell Cancer
por: Aydemirli, Mehtap Derya, et al.
Publicado: (2019)

Is Alcohol Consumption Related to Lifestyle Factors in Romanian University Students?
por: Năsui, Bogdana Adriana, et al.
Publicado: (2021)

LBODP096 High Failure Rate Of Radioactive Iodine-131 (Rai) Therapy For The Treatment Of Grave's Disease And Toxic Multinodular Goiter In An Urban Municipal Hospital Clinic
por: Handoo, Maryam Manzoor, et al.
Publicado: (2022)

Comparative Study on Nutrition and Lifestyle of Information Technology Workers from Romania before and during COVID-19 Pandemic
por: Nasui, Bogdana Adriana, et al.
Publicado: (2022)

Treating Hyperthyroidism with Radioactive Iodine
por: Harding, L K
Publicado: (1993)

Radioactive iodine and female fertility
por: Navarro, Pino, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kinj93jluk24jcau3aij0ql3o6